Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
The Canadian Journal of Cardiology|February 13, 2010
Achieving cholesterol targets by individualizing starting doses of statin according to baseline low-density lipoprotein cholesterol and coronary artery disease risk category: the CANadians Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (CanACTFAST) studyEhud Ur, Anatoly Langer, Simon W Rabkin, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 8, 2013
Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapySimon W Rabkin, Anatoly Langer, Ehud Ur, et al.
American Heart Journal|October 8, 2005
Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome RegistriesAmit Segev, Bradley H Strauss, Mary Tan, et al.
The Canadian Journal of Cardiology|April 11, 2008
Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issuesYola Moride, Robert A Hegele, Anatoly Langer, et al.
American Heart Journal|January 31, 2006
Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trialDavid H Fitchett, Anatoly Langer, Paul W Armstrong, et al.
The Canadian Journal of Cardiology|April 5, 2011
Use of a treatment optimization algorithm involving statin-ezetimibe combination aids in achievement of guideline-based low-density lipoprotein targets in patients with dyslipidemia at high vascular risk Guideline-based Undertaking to Improve Dyslipidemia Management in Canada (GUIDANC)Pamela M Katz, Aurora A Mendelsohn, Shaun G Goodman, et al.
The American Journal of Cardiology|January 16, 2007
Comparison of effectiveness of enoxaparin versus unfractionated heparin to reduce silent and clinically apparent acute myocardial infarction in patients presenting with non-ST-segment elevation acute coronary syndromeSanjit Jolly, Mary Tan, Aurora Mendelsohn, et al.
Coronary Artery Disease|July 18, 2009
Outcome of patients with acute coronary syndromes enrolled in clinical trialsAmit Segev, Paul Fefer, Bradley H Strauss, et al.
The Journal of Family Practice|October 10, 2008
How to reach LDL targets quickly in patients with diabetes or metabolic syndromeLawrence A Leiter, Pierre Martineau, Eduardo de Teresa, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 29, 2006
Bedtime administration of graded-release diltiazem in patients with inadequate BP control: a tolerability and efficacy studyDavid H Fitchett, Amparo Casanova, Shahin Jaffer, et al.
Pageof 12